In recent trading session, Alterity Therapeutics Ltd ADR (NASDAQ:ATHE) saw 15.49 million shares changing hands at last check today with its beta currently measuring 0.65. Company’s recent per share price level of $4.42 trading at $1.51 or 52.03% at last check today assigns it a market valuation of $39.24M. That most recent trading price of ATHE’s stock is at a discount of -6.56% from its 52-week high price of $4.71 and is indicating a premium of 77.38% from its 52-week low price of $1.00. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 21090.0 shares which gives us an average trading volume of 70.82K if we extend that period to 3-months.

Alterity Therapeutics Ltd ADR (NASDAQ:ATHE) trade information

Upright in the green today for gaining 52.03%, in the last five days ATHE remained trading in the green while hitting it’s week-highest on Thursday, 01/30/25 when the stock touched $4.42 price level, adding 24.7% to its value on the day. Alterity Therapeutics Ltd ADR’s shares saw a change of 33.66% in year-to-date performance and have moved 26.76% in past 5-day. Alterity Therapeutics Ltd ADR (NASDAQ:ATHE) showed a performance of 80.57% in past 30-days. Number of shares sold short was 84246.0 shares which calculate 1.04 days to cover the short interests.

Alterity Therapeutics Ltd ADR (ATHE) estimates and forecasts

This year revenue growth is estimated to fall -12.84% from the last financial year’s standing.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 24.86% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 50.35% while estimates for its earnings growth in next 5 years are of 29.75%.